Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

A patent foramen ovale (PFO) is found by transesophageal echocardiography in one half of patients with cryptogenic stroke (CS). Coagulation abnormalities may promote paradoxical emboli in these patients. Seventeen patients were identified with PFO and CS. Thirty-one percent of patients had hematologic risk factors for venous thrombosis. These included abnormal activated protein C resistance and increased anticardiolipin antibodies. Patients with coagulation abnormalities and a PFO were three times as likely to be treated with warfarin compared to aspirin (P<0.05). Prothrombotic states are common in patients with PFO and CS and identifying these conditions may impact the choice of antithrombotic therapy.

Original languageEnglish (US)
Pages (from-to)158-160
Number of pages3
JournalJournal of the Neurological Sciences
Volume160
Issue number2
DOIs
StatePublished - Oct 8 1998
Externally publishedYes

Fingerprint

Patent Foramen Ovale
Stroke
Activated Protein C Resistance
Anticardiolipin Antibodies
Transesophageal Echocardiography
Warfarin
Embolism
Venous Thrombosis
Aspirin

Keywords

  • Activated protein C resistance
  • Anticardiolipin antibodies
  • Ischemic
  • Patent foramen ovale
  • Stroke
  • Stroke, cryptogenic
  • Transesophageal echocardiography

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale. / Chaturvedi, Seemant.

In: Journal of the Neurological Sciences, Vol. 160, No. 2, 08.10.1998, p. 158-160.

Research output: Contribution to journalArticle

@article{aee4d633892249749dacbcedcf2efceb,
title = "Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale",
abstract = "A patent foramen ovale (PFO) is found by transesophageal echocardiography in one half of patients with cryptogenic stroke (CS). Coagulation abnormalities may promote paradoxical emboli in these patients. Seventeen patients were identified with PFO and CS. Thirty-one percent of patients had hematologic risk factors for venous thrombosis. These included abnormal activated protein C resistance and increased anticardiolipin antibodies. Patients with coagulation abnormalities and a PFO were three times as likely to be treated with warfarin compared to aspirin (P<0.05). Prothrombotic states are common in patients with PFO and CS and identifying these conditions may impact the choice of antithrombotic therapy.",
keywords = "Activated protein C resistance, Anticardiolipin antibodies, Ischemic, Patent foramen ovale, Stroke, Stroke, cryptogenic, Transesophageal echocardiography",
author = "Seemant Chaturvedi",
year = "1998",
month = "10",
day = "8",
doi = "10.1016/S0022-510X(98)00243-3",
language = "English (US)",
volume = "160",
pages = "158--160",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale

AU - Chaturvedi, Seemant

PY - 1998/10/8

Y1 - 1998/10/8

N2 - A patent foramen ovale (PFO) is found by transesophageal echocardiography in one half of patients with cryptogenic stroke (CS). Coagulation abnormalities may promote paradoxical emboli in these patients. Seventeen patients were identified with PFO and CS. Thirty-one percent of patients had hematologic risk factors for venous thrombosis. These included abnormal activated protein C resistance and increased anticardiolipin antibodies. Patients with coagulation abnormalities and a PFO were three times as likely to be treated with warfarin compared to aspirin (P<0.05). Prothrombotic states are common in patients with PFO and CS and identifying these conditions may impact the choice of antithrombotic therapy.

AB - A patent foramen ovale (PFO) is found by transesophageal echocardiography in one half of patients with cryptogenic stroke (CS). Coagulation abnormalities may promote paradoxical emboli in these patients. Seventeen patients were identified with PFO and CS. Thirty-one percent of patients had hematologic risk factors for venous thrombosis. These included abnormal activated protein C resistance and increased anticardiolipin antibodies. Patients with coagulation abnormalities and a PFO were three times as likely to be treated with warfarin compared to aspirin (P<0.05). Prothrombotic states are common in patients with PFO and CS and identifying these conditions may impact the choice of antithrombotic therapy.

KW - Activated protein C resistance

KW - Anticardiolipin antibodies

KW - Ischemic

KW - Patent foramen ovale

KW - Stroke

KW - Stroke, cryptogenic

KW - Transesophageal echocardiography

UR - http://www.scopus.com/inward/record.url?scp=0032497620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032497620&partnerID=8YFLogxK

U2 - 10.1016/S0022-510X(98)00243-3

DO - 10.1016/S0022-510X(98)00243-3

M3 - Article

C2 - 9849798

AN - SCOPUS:0032497620

VL - 160

SP - 158

EP - 160

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 2

ER -